Pharmatizing AI

Digital

In this off-the-stage interview from Frontiers Health 2025 discover how 'pharmatized' AI delivers smarter, faster, and more reliable innovation.

News

Hengrui's oral TPO agonist, hetrombopag, is the first in the class to be approved for thrombocytopenia caused by chemotherapy for solid tumours.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.